300,000
Clinical Trial Records
60,000
Product/Candidates
50,000
Sponsor/Organisation
March 11,2022 12:38 PM
SciSparc Launches New JV Targeting Discovery Of Potential Drugs For Cancers And Infectious Diseases
March 11,2022 12:37 PM
Health Canada Approves Samsung Bioepis And Biogens BYOOVIZ™ (SB11), LUCENTIS® Biosimilar (ranibizumab)
March 11,2022 12:33 PM
Lupin Launches First Reference Lab In Kolkata
March 11,2022 12:31 PM
Antengenes Xpovio Gets Australian TGA Approval To Treat R/R MM & Triple Class-refractory Multiple Myeloma
March 10,2022 12:12 PM
Insightec Receives FDA Ide Approval And Breakthrough Designation For Nsclc Brain Mets Study And Ide Approval For Liquid Biopsy Study
March 11,2022 12:40 PM
Everest Medicines Announces That Licensing Partner Venatorx Pharmaceuticals Reports Positive Results From Pivotal Phase 3 Cefepime-Taniborbactam Trial
March 10,2022 11:55 AM
Pfizer Begins Phase 2/3 Study Of Novel Covid-19 Oral Treatment In Paediatric Participants
March 09,2022 10:39 AM
Aldeyra Therapeutics Initiates Phase 2 Clinical Trial Of ADX-2191 For The Treatment Of Retinitis Pigmentosa
March 09,2022 10:30 AM
Kintor Pharma Completes Patient Enrollment In Phase II Trial Of KX-826 In China To Treat Female Patients With Androgenetic Alopecia
March 08,2022 10:43 AM
Kintor Pharma Announces Completion Of Patient Enrollment In Phase II Clinical Trial Of KX-826 In China For The Treatment Of Androgenetic Alopecia In F
March 07,2022 10:19 AM
I Mab Receives FDA Orphan Drug Designation For Cancer Drug
March 04,2022 10:10 AM
Inhibrx Receives FDA Orphan Drug Designation For INBRX 101 For The Treatment Of Alpha 1 Antitrypsin Deficiency
March 03,2022 10:28 AM
China NMPA Grants Breakthrough Designation To Innovent Biologics & AnHeart Therapeutics Taletrectinib In ROS1-positive NSCLC
March 01,2022 10:22 AM
Innovent Biologics And AnHeart Therapeutics Receive NMPA Breakthrough Designation For Taletrectinib In ROS1-Positive Non-Small Cell Lung Cancer
February 26,2022 11:01 AM
Boehringers Idiopathic Pulmonary Fibrosis Drug Gets Breakthrough Designation
March 11,2022 12:34 PM
Cerveau Technologies Inc. Signs Agreement With Roche To Provide Novel Tau Imaging Biomarker For Disease Modifier Research
March 11,2022 12:32 PM
Dedalus Ibex Ink Partnership To Bring Power Of Artificial Intelligence To Digital Pathology
March 10,2022 11:37 AM
Twist Bioscience And Kriya Sign Agreement To Discover Novel Antibodies For Applications In Oncology Using Gene Therapy
March 09,2022 10:27 AM
EKF Life Sciences And ABEC Partner For US Biomanufacturing Expansion
March 08,2022 10:34 AM
Johnson & Johnson, Biopharma Turn To China For Innovative Collaborations
Clinical trials data Insight in all Regulated Market, which includes and not limited to US, EU, AUS & NZ, Japan, Canada & India.
Clinical trials data Insight on over 3,00,000 clinical trials from Phase 0 to IV across all indication includes, Orphan disease and Therapy Area.
Sponsor key contacts on over 50,000 companies along with its category as Large, Mid and Small companies for identifying licensing candidates.
Clinical trial data coverage of over 60,000 Molecules of all Regulated Markets.
Pipeline Analysis of Company.
Key Information to help CRO for Outsourcing Projects.
Molecules categorised as Biologics Vs. Small Molecules to hit the right target for Licensing candidates.
News Alerts on Deals, In-Licensing, Out-licensing, Clinical Trial Development of molecules, Safety and efficacy data.
Orphan drug designation insights on all candidates
Fast track & Breakthrough designation by regulatory body.
